Brodsky et al. [35] confirmed that the up-regulation of COL10A1 is closely associated with poor prognosis of breast cancer when analysing the gene expression of patients treated with HER2-targeted therapy and neoadjuvant chemotherapy. This evidence concerns the gene COL10A1 and breast carcinoma.